VIDEO 5:

Efficacy of Dupilumab for Moderate-to-Severe
Atopic Dermatitis

Jeffrey M. Weinberg, MD

CHAPTER 1
CHAPTER 2
CHAPTER 3
CHAPTER 4
CHAPTER 5

This activity is jointly provided by Global Education Group and
Integritas Communications.

This activity is supported by an educational grant from Genzyme,
a Sanofi Company, and Regeneron Pharmaceuticals.